CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea · Delayed Price · Currency is KRW 1,990.00
-9.00 (-0.45%)
At close: Dec 5, 2025
CMG Pharmaceutical Market Cap
CMG Pharmaceutical has a market cap or net worth of 294.21 billion as of December 5, 2025. Its market cap has increased by 1.11% in one year.
Market Cap
294.21B
Enterprise Value
325.02B
Revenue
100.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,990.00
Market Cap Chart
Since March 1, 2002, CMG Pharmaceutical's market cap has increased from 11.27B to 294.21B, an increase of 2,510.58%. That is a compound annual growth rate of 14.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 294.21B | 19.81% |
| Dec 30, 2024 | 245.56B | -26.64% |
| Dec 28, 2023 | 334.73B | 12.09% |
| Dec 29, 2022 | 298.62B | -43.94% |
| Dec 30, 2021 | 532.65B | -33.65% |
| Dec 30, 2020 | 802.80B | 36.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.30T |
| ALTEOGEN | 27.86T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8.91T |
| LigaChem Biosciences | 6.91T |
| Peptron | 6.67T |